Cyclosporine for dry eye shows significant improvement in symptoms, according to phase II study
Publish date: May 1, 2009
Phase II of a clinical study examining a formulation of cyclosporine (Cyclokat, Novagali Pharma) has been completed, and results demonstrate statistically significant improvement with signs and symptoms in patients suffering from moderate-to-severe dry eye syndrome.